EUCTR2012-000851-15-GB进行中（未招募）1 期
What is the clinical and cost effectiveness of oral steroids in the treatment of acute lower respiratory tract infection (LRTI)? A placebo controlled randomised trial - The Oral Steroids for Acute Cough (OSAC) Trial
niversity of Bristol0 个研究点目标入组 398 人开始时间: 2012年10月25日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 398
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •All must apply: • Adults (=18 years) presenting to primary care (general practices) requesting advice for an acute (28 days) cough as the main symptom and; • At least 1 symptom localizing to the lower respiratory tract and suggestive of an acute lower respiratory tract infection (sputum, chest pain, shortness of breath, wheeze) and; • Patient’s first time in the OSAC trial and; • Patient and primary care site are able to consent and randomise the patient by the end of the (working) day of presentation and; • Patient is immunocompetent and; • Patient has capacity and willingness, in the view of the recruiting clinician, to give informed consent and complete the trial paperwork, including the symptom diary, and; • Patient is willing to receive a weekly telephone call from the trial team.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 392
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 44
排除标准
- •The presence of any warrants exclusion: • Age <18 years or; • Patients unable to give informed consent or complete the trial paperwork, including the symptom diary, through mental incapacity, e.g. due to: o Major current psychiatric illness o Learning difficulties o Dementia or; • Patients unwilling to complete the trial symptom diary or unwilling to receive a weekly telephone call from the trial team; • Pregnant or intending to become pregnant (or unwilling to use reliable form of contraception) in the next month or; • Currently breast-feeding/lactating or; • Recruiting primary care site is not the patient's usual practice or if the patient is not expecting to still be with the primary care site in 3 months (i.e. temporary residents) or; • Patient has previously taken part in the OSAC trial or; • Involvement in another clinical drug trial in the last 90 days or any other respiratory related research within the last 30 days or; • Known immune-deficiency (e.g. HIV, active chemotherapy or advanced cancer) or; • Cough >28 days or; • No lower respiratory tract symptoms or signs (sputum, chest pain, shortness of breath, wheeze) or; • Patients with an 'active' diagnosis of asthma (for which treatment has been given in the past 2 years) or; • Patients without a definite history of chickenpox and a recent (= 28 days) history of close personal contact with chickenpox or herpes zoster or; • Unable to swallow tablets or; • Clinically very unwell or with symptoms and signs suggestive of pneumonia (as per the British Thoracic Society Guidelines e.g. tachypnoea, unilateral chest signs of consolidation or hypoxia (oxygen saturation <94%) or other systemic infection (e.g. suspected bacteraemia) or; • Patients at higher risk of complications, who according to NICE, warrant immediate antibiotic treatment (NB use of delayed prescription does not preclude OSAC trial participation). These include patients with: o Chronic heart, lung (e.g. chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis), renal, liver or neuromuscular disease or immunosuppression; or with complications from previous episodes of lower respiratory tract infection (e.g. hospital admission for pneumonia) or; o Patients older than 65 years with two or more of the following criteria, or older than 80 years with one or more of the following criteria: • Unplanned hospitalisation in previous year, • Type 1 or type 2 diabetes • History of cardiac failure • Unable to complete recruitment process by the end of the day of presentation or; • Recent (=1 month) use of any inhaled corticosteroids or; • Recent (=1 month) use of any short course (?1 week) systemic corticosteroids or; • Current or previous (=12 months) long term (= 1 week course) use of systemic steroids or; • Known contra-indications or cautions to oral steroids including: o Uncontrolled diabetes (HbA1c >8%) o Peptic ulcer disease o Previous TB o Known allergy to Prednisolone or other tablet ingredients (potato starch, lactose monohydrate, colloidal silicon dioxide, sodium starch glycolate, magnesium stearate), galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption o Suspected ocular herpes simplex o Cushing’s disease o Osteoporosis o Uncontrolled hypertension o Severe affective disorders (e.g. manic depression, previous steroid psychosis) o Glaucoma o Previous steroid myopathy o Epilepsy o Intenti
研究者
相似试验
已完成
不适用
nited Kingdom Rotator Cuff TrialISRCTN97804283niversity of Oxford (UK)270
已完成
3 期
Treatment of essential hand tremor: Dysport versus propranololessential hand tremor.Essential tremorIRCT201607022415N2Vice chancellor for research, army university of medical Sciences78
已完成
不适用
The Oral Steroids for Acute Cough (OSAC) TrialISRCTN57309858niversity of Bristol (UK)436
招募中
不适用
Treatment success and user friendlyness of the Oral-B app.plaque-indexhealthy probandsDRKS00013560Zentrum für Zahnmedizin der Universität Zürich20
尚未招募
4 期
Effect and costs of methods to avoid tooth decay in poor 6 - 7 year old children in Bengaluru city - an experiment done in the school premisesCTRI/2015/06/005946The Oxford Dental College440